Who are the ADC Contract Manufacturing Market Top Companies and What are Their Offerings?
| Companies | Headquarters | ADC Contract Manufacturing Services |
| Lonza Group | Basel, Switzerland | End-to-end services |
| Axplora (Novasep) | Raubling, Germany | ADC manufacturing services |
| WuXi Biologics | Wuxi, China | One-stop shop platform for payloads, dug products, and linker discovery, CMC, and GMP manufacturing. |
| MilliporeSigma (Merck KGaA) | Darmstadt, Germany | Comprehensive CDMO services |
| Samsung Biologics | Incheon, South Korea | Large-scale antibody manufacturing |
| Cambrex | East Rutherford, U.S. | Expanded large-scale capacity for ADC payloads and linker |
| Catalent, Inc. | Somerset, U.S. | Bioconjugation, fill-finish, and analytical testing |
| Sterling Pharma Solutions | Cramlington, UK | ADC bioconjugation and development |
| Piramal Pharma Solutions | Mumbai, India | Integrated ADC services |
| Abzena | San Diego, U.S. | ThioBridge conjugation technology |
Recent Developments in the ADC Contract Manufacturing Market
- In April 2026, a strategic collaboration between Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services was announced to enhance the ADC platform by providing manufacturing support for AJICAP-based products. The clients seeking ADC manufacturing technology will be directed to Aji Bio-Pharma and AJICAP by Piramal, while Aji Bio-Pharma will recommend the clients to Piramal for CDMO services for manufacturing products using AJICAP technology.
- In September 2025, a collaboration between Mycenax Biotech Inc., which is a leading biologics CDMO, and Spera Pharma Inc., which is an expert in pharmaceutical chemistry, manufacturing, and controls (CMC), was announced. The alliance will provide an integrated and cost-effective ADC development and manufacturing platform as well as deliver a seamless, one-stop solution tailored for global clients.
ADC Contract Manufacturing Market Value Chain Analysis
R&D
- The R&D of the ADC contract manufacturing focuses on the development of site-specific conjugation platforms and automated high containment technologies.
- Key players: Lonza Group, Abzena, WuXi Biologics.
Formulation and Final Dosage Preparation
- Specialised ADC formulation and aseptic fill-finish services focused on lyophilisation are provided in the formulation and final dosage preparation of the ADC contract manufacturing.
- Key players: Lonza Group, WuXi Biologics, Piramal Pharma Solutions.
Packaging and Serialization
- Specialized secondary packaging line, integrated track-and-trace software, and global GS1-compliant serialization are used in the packaging and serialization of the ADC contract manufacturing.
- Key players: WuXi Biologics, Catalent, Inc., Thermo Fisher Scientific.
Distribution to Hospitals, Pharmacies
- Ultra-secure and temperature-controlled cold chain distribution to hospitals and pharmacies is provided in the ADC contract manufacturing.
- Key players: Thermo Fisher Scientific, McKesson, Cardinal Health.
Patient Support and Services
- Patient treatment adherence monitoring, financial assistance programs, and injection training are provided in the patient support and services of the ADC contract manufacturing.
- Key players: McKesson, Cardinal Health, CVS Specialty.
Market Growth
The global ADC contract manufacturing market size was estimated at USD 6.8 billion in 2025 and is predicted to increase from USD 7.68 billion in 2026 to approximately USD 22.88 billion by 2035, expanding at a CAGR of 12.9% from 2026 to 2035. The growing cancer burden globally is increasing the demand for ADC products, driving the adoption of ADC contract manufacturing. Growing R&D activities, funding, government support, outsourcing trends, technological advancements, and collaborations are enhancing the market growth.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking